FIELD: medicine, pharmaceutics.;SUBSTANCE: present invention refers to 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one heminapadisylate of formula (I) wherein n is equal to 2, and to pharmaceutically acceptable solvates thereof. Also, the invention refers to a pharmaceutical composition of the salt of formula (I), to a method of treating the above pathological conditions and to using the salt of formula (I) and to the pharmaceutical composition thereof.;EFFECT: what is prepared is the new salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one effective in treating the pathological pulmonary conditions, particularly asthma or chronic obstructive pulmonary disease.;11 cl, 3 dwg, 6 ex
展开▼
机译：领域：本发明涉及5-（2-{[6-（2,2-二氟-2-苯基乙氧基）己基]氨基} -1-羟乙基）-8-羟基喹啉-2（1H） ）-式（I）的一半氨基二甲磺酸酯其中n等于2，并且在药学上可接受的溶剂化物。另外，本发明涉及式（I）的盐的药物组合物，治疗上述病理状况的方法以及使用式（I）的盐及其药物组合物。效果：制备了什么是5-（2-{[6-（2,2-二氟-2-苯基乙氧基）己基]氨基} -1-羟乙基）-8-羟基喹啉-2（1H）的新盐，可有效治疗病理肺部疾病，尤其是哮喘或慢性阻塞性肺疾病。; 11 cl，3 dwg，6 ex
展开▼
